FBFrancisco Cesar Barroso Barbosa

Francisco Cesar Barroso Barbosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francisco Cesar Barroso Barbosa has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Detection of mcr-1 and mcr-2 Genes among Escherichia coli and Klebsiella pneumoniae with One Health Approach for Antimicrobial Resistance in Brazil

    by Erika Alexandra Daza-Cardona, Paulo de Tarso Teles Dourado de Aragão, Jhon Buenhombre, Guilherme Mendes Prado, Maria Nelly Cajiao-Pachón, Raquel Oliveira dos Santos Fontenelle, Francisco Cesar Barroso Barbosa

    Nowadays, antimicrobial resistance is recognized as one of the most important global human health problems in the 21st century. Antimicrobial-resistant microorganisms can disseminate between ecosystems and have been found in humans, food, animals, plants and the environment. This study aimed to detect and characterize the mcr gene´s presence responsible for colistin resistance in Enterobacteriaceae isolates from humans, animals, the environment and food in Northeastern Brazil. The molecular identification of the mcr-1 and mcr-2 was carried out through the polymerase chain reaction (PCR), followed by an electrophoretic run. In isolates in which mcr genes were detected, the sensitivity profile for colistin was evaluated using the Broth Microdilution method. In total, 50 specimens of Escherichia coli from humans (n=14), poultry (n=19), cheese (n=12) and water (n=5) and 16 specimens of Klebsiella pneumoniae isolated from humans were analyzed. The mcr-2 gene was not detected in any isolate. Three of the 30 K. pneumoniae isolates (10%) positives for the mcr-1 gene were recovered from human clinical samples, one of the 19 E. coli isolates (5.3%) was retrieved from poultry, and one of the 12 E. coli isolates (8.3%) was recovered from cheese. The E. coli strains positive for the mcr-1 gene showed a resistance profile to colistin sulfate with MIC of 4 µg/mL, and K. pneumoniae strains showed an intermediate profile to colistin (MIC < 0,25 µg/mL). Hence, these data unveil that enterobacteria from various sources can carry the mcr-1 gene, conferring resistance to colistin, and that the gene is circulating in Northeastern Brazil. The discovered results make a crucial contribution to molecular and epidemiological surveillance within a One Health framework, aiming to prevent the dissemination of these genes both within and beyond the region.


  • Development of silanized bacterial cellulose aerogels for the incorporation of natural oils with healing properties: Copaiba (Copaifera officinalis), bourbon geranium (Pelargonium X ssp.) essential oils and buriti (Mauritia flexuosa) vegetable oil

    by Evellheyn Rebouças Pontes, Luciana de Souza Guedes, Thamyres Freire da Silva, Francisco Cesar Barroso Barbosa, Bartolomeu Warlene Silva de Souza, Morsyleide de Freitas Rosa, Rodrigo Silveira Vieira, Fábia Karine Andrade


  • Open Access

    Antimicrobial Susceptibility and Molecular Epidemiology of Multidrug-resistant Pseudomonas aeruginosa in Northeast of Brazil

    by Stephanie de Almeida-Alves, Ludimila Gomes Pinheiro, Izabelly Linhares Ponte-Brito, Paulo de Tarso Teles Dourado de Aragão, Guilherme Mendes Prado, Júlio César Sousa Prado, Raquel Oliveira dos Santos Fontenelle, Francisco Cesar Barroso Barbosa

    Introduction: This study aimed to investigate the antimicrobial susceptibility profile of nosocomial strains of Pseudomonas aeruginosa isolated from inpatients of a teaching hospital in the City of Sobral, Ceará, in Northeast of Brazil (Santa Casa de Misericórdia de Sobral - SCMS) from March/2019 to March/2020, as well as to assess the occurrence of resistance genes bla-TEM, bla-SHV, bla-CTX-M 1/2, bla-IMP-1, bla-KPC, bla-GES, bla-SPM-1, bla- NDM-1, bla-VIM. Methodology: Bacterial identification and antimicrobial susceptibility tests (AST) were performed using the automated system Vitek®2. Conventional polymerase chain reaction (PCR) was used to amplify genes of interest. Results: Thirty-eight specimens of P. aeruginosa were collected. More than half of the isolates were resistant to imipenem (55.2%), and showed different rates of resistance to the other antimicrobials tested. In addition, intermediate susceptibility was also observed to gentamicin (7.8% of the isolates) and meropenem (10.52% of the isolates). The gene bla-CTX-M 1/2 was the most prevalent (41.9%), while bla-GES was highly identified among the carbapenemase-producing strains (12.9%). Conclusion: The results demonstrated considerable resistance rates to β-lactam antibiotics, which could be attributable to the indiscriminate use of these antibiotics in the analyzed hospital, whose control relies on the improvement of antimicrobial prescription policies.

  • Open Access

    Antifungal, molecular docking and cytotoxic effect of the essential oil of Cymbopogon citratus (DC) Stapf. and Cymbopogon nardus (L.) Rendle against Candida albicans

    by Guilherme M. Prado, Júlio César S. Prado, Francisca Lidiane L. DE Aguiar, Francisco Cesar B. Barbosa, Jean P.C. Do Vale, Maria Rosário Martins, Silva Macedo Arantes, Natália V. DE Sousa, Danielle M. Lima, Emmanuel S. Marinho, et al.

    Brazil is renowned for its extensive plant biodiversity, with emphasis on Cymbopogon, C. citratus and C. nardus, with broad antimicrobial potential. Candidemias caused by Candida albicans are highly prevalent in immunosuppressed individuals and are associated with infections by biofilms on medical devices. The aim of this study was to evaluate the antimicrobial potential of essential oils C. citratus and C. nardus against C. albicans in planktonic and biofilm forms. Essential oils were obtained by hydrodistillation and chemical composition evaluated by GC-FID and GC-MS. The minimum inhibitory concentration was determined by the broth microdilution method and the synergy effect of essential oils and amphotericin B were evaluated by the checkerboard test. Biofilm activity was determined by the XTT assay. Cytotoxicity assays performed with VERO cells and molecular docking were performed to predict the effect of oil interaction on the SAP-5 enzyme site. The results showed activity of essential oils against planktonic cells and biofilm of C. albicans. Furthermore, the oils had a synergistic effect, and low cytotoxicity. Molecular docking showed interaction between Cadinene, Caryophyllen oxide, Germacrene D with SAP-5. The results indicate that Cymbopogon spp. studied are anti-Candida, with potential for further application in therapy against infections caused by C. albicans.


  • Open Access

    Cymbopogon sp. from ethnobotany to antimicrobial: an integrative review

    by Guilherme Mendes Prado, Júlio Cesar Sousa Prado, Carlos Victor Fontenele Pinheiro, Erika Alexandra Daza-Cardona, Francisco César Barroso Barbosa, Elnatan Bezerra de Souza, Raquel Oliveira dos Santos Fontenelle

    Considering the broad potential of the genus Cymbopogon, here we present a systematic literature survey on it’s antimicrobial potential. This is a review, articles from the Scielo and PubMed platforms. The articles surveyed were published between 2015 and 2020, with the theme of microbiology, including ethnobotanical studies, literature reviews, in vitro, in vivo, reports of clinical trials. Works outside the selected period, duplicate articles, and those only reporting infections of plants by the microorganism were excluded. 98 studies were selected, 74% found in PubMed and 26% in Scielo. Of this total, 21% were ethnobotanical/ethnopharmacology or literature reviews, most of them reporting the use of infusions of the species C. citratus (DC.) Stapf. Moreover, in 57% of the studies, survey respondents did not report antimicrobial use. In relation to 79% of the experimental studies, it was observed that 77% reported total inhibition of microbial growth, 3% indicated moderate growth inhibition, 4% low growth inhibition and 5% reported no inhibition. Among the microbial species analyzed were Escherichia coli, Pseudomonas aeruginosa, Borrelia burgdorferi, Candida albicans, Salmonella enterica and Saccharomyces cerevisiae. In addition, 5% of the articles reported antiviral activity, 5% parasitic control, 1% preventive action against contamination by mesophilic microorganisms. Although the population is not aware of the antimicrobial activity of Cymbopogon sp., studies have demonstrated its antimicrobial potential, thus the extracts of this genus can be an alternative for use in folk medicine as well as a source of new drugs with antimicrobial action.


  • Open Access

    Inhibitory and bactericidal activities of Lippia origanoides essential oil against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa multidrug resistant

    by Ludimila Gomes Pinheiro, Raquel Oliveira dos Santos Fontenelle, Tigressa Helena Soares Rodrigues, Vicente de Paulo Teixeira Pinto, Francisco Cesar Barroso Barbosa

    The objective of this study was to evaluate the antimicrobial potential of essential oil (EO) from L. origanoides against Gram-negative bacteria with multidrug resistance (MDR) phenotype and to correlate the results obtained with the genetic profile of these microorganisms. The oil was extracted from the leaves of this plant by steam dragging and condensation with Clevenger equipment, the chemical components were identified and quantified by gas chromatography coupled with mass spectrometry and gas chromatography coupled with the flame ionization detector. Twenty clinical isolates and one standard strain of each species were analyzed: E. coli, K. pneumoniae and P. aeruginosa (n=63). The antibacterial potential was evaluated by broth microdilution tests. Thymol is the prevalent component (87.37%). The EO at a concentration of 312 μg/mL was effective in inhibiting 52% of E. coli strains and about 38% of K. pneumoniae. On the other hand, for P. aeruginosa a concentration of 2,500 μg/mL was needed to obtain growth inhibition of approximately 38% of the strains. Among the resistance genes detected, the highest prevalence was blaCTX-M 1/2, however, even with the presence of these genes, an antimicrobial action of this EO was observed. Therefore, the results of this study suggest that the EO of L. origanoides presented an efficient antibacterial action with potential use in the fight against infections by MDR microorganisms.


  • Open Access

    Antifungal activity, antibiofilm and synergic effect of diallyl disulfide and diallyl trisulfide against Candida albicans

    by Rafael Pereira, Guilherme Mendes Prado, Raquel Oliveira dos Santos Fontenelle, Francisco César Barroso Barbosa, Hélcio Silva dos Santos, Emmanuel Silva Marinho, Márcia Machado Marinho, Selene Maia de Morais

    The objective of the present study was to determine the antifungal activity, antibiofilm and synergic effect of the compounds diallyl disulfide and diallyl trisulfide in combination with antifungal agents against clinical isolates of Candida albicans, including also a computational study. Antimicrobial sensitivity tests were performed using the broth microdilution method to determine the minimum inhibitory concentration against C. albicans strains and modulatory activity using the checkerboard technique. The biofilm formation was evaluated by biomass quantification using the violet crystal staining method. For the study of molecular docking computer simulations. The constituents showed relevant antifungal activity against strains of C. albicans. In the modulatory activity assay, demonstrated a synergistic interaction with fluconazole and amphotericin B, with an increase in its antifungal action. The diallyl disulfide, diallyl trisulfide and fluconazole ligands formed complexes with ALS3 enzyme. Then, both compounds were considered promising products for the development of new drugs to prevent candidiasis.


  • Open Access

    Late mesenteric ischemia after Sars-Cov-2 infection: case report

    by Vilson Sovio Oliveira de Macedo, Geterson Bezerra Moreira, Ana Cristina Fiuza de Albuquerque, Sebastião Carlos de Sousa Oliveira, Mateus Aragão Esmeraldo, Francisco Cesar Barroso Barbosa

    The purpose of this article is to report the case of a 53-year-old black man, with no previous comorbidities, who presented 48 days after a confirmed diagnosis of COVID-19, complaining of an initially insidious epigastric pain that had progressed to severe pain radiating to the interscapular vertebral region, with hyporexia and episodes of projectile vomiting, with no nausea or fever. Laboratory tests revealed no signs of acute infection or pancreatic injury. Abdominal computed tomography showed dilated, fluid-filled small bowel loops with thickened walls. After clinical treatment, the patient developed persistent abdominal pain. An exploratory laparotomy was performed, finding two sites of small bowel stenosis, with no extrinsic cause, and signs of local ischemia and considerable distension of jejunal and ileal loops. After enterectomy and side-to-side enteroanastomosis, the patient recovered satisfactorily and was discharged with a prescription for oral anticoagulants for outpatient use.


  • Open Access

    AUTOPERCEPÇÃO EM SAÚDE BUCAL DE PACIENTES COM HIV/AIDS ACOLHIDOS POR CASA DE APOIO

    by Amanda Sales de Almeida, Jacques Antonio Cavalcante Maciel, Francisco César Barroso Barbosa

    Este artigo analisa a autopercepção em saúde bucal de pacientes com vírus da imunodeficiência humana e síndrome da imunodeficiência adquirida (HIV/AIDS) acolhidos pela Casa de Apoio “Madre Anna Rosa Gattorno” em Sobral-CE, descrevendo os fatores relacionados e associando o perfil socioeconômico e educacional ao cuidado em saúde bucal. A coleta de dados foi realizada com aplicação de questionários a 72 pacientes. Quanto às características sociodemográficas, a maioria dos sujeitos do estudo relatou baixas escolaridade e renda. Observou-se que 88,9% se preocupavam com a saúde bucal; 90,3% percebiam a influência da condição bucal na saúde geral; e a cárie foi a principal causa de dor. Os resultados sugerem a necessidade de planejar, elaborar e executar serviços odontológicos voltados à promoção da saúde de pacientes com HIV/AIDS, possibilitando a tomada de ações específicas para melhorar a qualidade de vida dessa clientela.